Highlights Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 09:05:45 08/05/2026 pm IST			5-day change	1st Jan Change
36.98 ^EUR	-1.20%		-2.81%	-0.08%

08/05	BAYER AG : UBS maintains a Buy rating	ZD
08/05	UBS maintains 'Buy' rating on Bayer - Target 52 euros	DP

Highlights

07/05	Bayer Announces Positive Topline Results from the Phase III REVEAL Study	CI
06/05	Bayer Bolsters Ophthalmology Pipeline with $2.45 Billion Perfuse Therapeutics Deal	MT
06/05	Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion -- Update	DJ
06/05	Bayer's experimental blood thinner cuts risk and severity of repeat strokes	RE
06/05	Bayer Bolsters Ophthalmology Pipeline with $2.45 Billion Perfuse Therapeutics Deal Bayer Bolsters Ophthalmology Pipeline with $2.45 Billion Perfuse Therapeutics Deal	MT
06/05	Bayer Aktiengesellschaft entered into an agreement to acquire Perfuse Therapeutics, Inc. for $2.5 billion.	CI
06/05	New study data bolsters Bayer's hopes for Asundexian	RE
06/05	Bayer to acquire Perfuse Therapeutics for deal valued up to $2.45 billion	RE
06/05	Bayer to Buy Perfuse Therapeutics in $2.45 Billion Deal	MT
06/05	Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal	RE
06/05	Bayer acquires ophthalmology specialist	RE
06/05	Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion	DJ
06/05	Bayer bolsters ophthalmic pipeline with U.S. acquisition	DP
30/04	Syngenta sees strong growth in China as Q1 sales rise	RE
30/04	Syngenta sees strong growth in China as Q1 sales rise	RE
29/04	Italian Pharma Group Chiesi to Acquire U.S. Rival KalVista	RE
29/04	Bayer's Marketing Authorization Application for Stroke Prevention Drug Accepted in China	MT
28/04	Mwb: US Supreme Court Hearing Marks Progress for Bayer in Roundup Litigation; Buy Reaffirmed	MT
28/04	Safety Label Case for Bayer's Roundup Draws Split Reception at US Top Court	MT
28/04	Glyphosate Litigation: Bayer Commends Supreme Court's Diligent Review	DP
28/04	Bayer shares slide after U.S. Supreme Court split over Bayer's fight against Roundup lawsuits	RE
28/04	UBS maintains 'Buy' rating on Bayer - Target 52 euros	DP
28/04	U.S. Supreme Court divided over Bayer glyphosate litigation	RE
28/04	US Supreme Court hears Bayer's fight against Roundup lawsuits	RE
28/04	Health Care Up on Deal Activity -- Health Care Roundup	DJ